H
Hoogenboom Hendricus R J M
Researcher at Medical Research Council
Publications - 31
Citations - 5582
Hoogenboom Hendricus R J M is an academic researcher from Medical Research Council. The author has contributed to research in topics: Phagemid & Antigen. The author has an hindex of 11, co-authored 31 publications receiving 5582 citations.
Papers
More filters
Patent
Methods for producing members of specific binding pairs
John Mccafferty,Anthony Richard Pope,Kevin Stuart Johnson,Hoogenboom Hendricus R J M,Andrew D. Griffiths,Ronald Henry Jackson,Kaspar Philipp Holliger,James D. Marks,Timothy Piers Clackson,David John Chiswell,Gregory Paul Winter,Timothy Peter Seattle Bonnert +11 more
TL;DR: In this paper, a member of a specific binding pair (sbp) is identified by expressing DNA encoding a genetically diverse population of such sbp members in recombinant host cells in which the sbps members are displayed in functional form at the surface of a secreted recombinant genetic display package (rgdp) containing DNA encoding the sbp member or a polypeptide component thereof.
Patent
Production of anti-self antibodies from antibody segment repertoires and displayed on phage
Andrew David Griffiths,Hoogenboom Hendricus R J M,James D. Marks,John Mccafferty,Gregory Paul Winter,Geoffrey Walter Grigg +5 more
TL;DR: In this paper, the authors described methods for the production of anti-self antibodies and antibody fragments, being antibodies or fragments of a particular species of mammal which bind self-antigens of that species.
Patent
Human antibodies that bind human tnf.alpha.
Jochen G. Salfeld,Allen Deborah J,Hoogenboom Hendricus R J M,Zehra Kaymakcalan,Boris Labkovsky,John A. Mankovich,Brian T. Mcguinness,Roberts Andrew J,Paul Sakorafas,David Schoenhaut,Tristan J. Vaughan,Michael White,Alison Jane Wilton +12 more
TL;DR: In this article, a method for inhibiting the human tumor necrosis factor (TNF) activity, including contact between the human TNF α and an antibody, is provided, wherein the antibody is the isolated human antibody dissociating from the humanTNF α at rate constants of K d below 1×10 -8 M and K off below 1x10 -3 s -1 or its antigen-binding portion, both of which are measured by surface plasmon resonance, and the antibody neutralizes the cytotoxicity of the human L929 assay at IC 50 below
Patent
Production of anti-self bodies from antibody segment repertories and displayed on phage
Andrew David Griffiths,Hoogenboom Hendricus R J M,James D. Marks,John Mccafferty,Gregory Paul Winter,Geoffrey Walter Grigg +5 more
TL;DR: In this article, the authors described methods for the production of anti-self antibodies and antibody fragments, being antibodies or fragments of a particular species of mammal which bind self antigens of that species.
Patent
Human antibodies that bind human TNFalpha
Jochen G. Salfeld,Allen Deborah J,Hoogenboom Hendricus R J M,Zehra Kaymakcalan,Boris Labkovsky,John A. Mankovich,Brian T. Mcguinness,Roberts Andrew J,Paul Sakorafas,David Schoenhaut,Tristan J. Vaughan,Michael White,Alison Jane Wilton +12 more
TL;DR: In this paper, recombinant human antibodies that specifically bind to human tumor necrosis factor α (hTNFα) are disclosed, which are useful for detecting and inhibiting human TNFα activity.